FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jacqueline Savary

Research Profile

Concepts & Ideas

Chemicals & Drugs

Procedures

Disorders

Living Beings

Professional Staff Committees

Occupations

Medical Oncology

Co-author Network

Publications

TOP 3
Xavier Pivot; Christine Chevreau; Didier Cupissol; Alain Lortholary; Nguyen Binh Bui; Jean-Christophe Eymard; Jacques-Olivier Bay; Marie-Christine Baranzelli; Monica Mita; Laurence Barnouin; Jacqueline Savary; Antoine Thyss
Phase II trial of paclitaxel-epirubicin in patients with recurrent soft-tissue sarcoma.
Xavier Pivot; L Cals; Didier Cupissol; Emmanuel Guardiola; X Tchiknavorian; P Guerrier; L Merad; J L Wendling; L Barnouin; Jacqueline Savary; Antoine Thyss; M Schneider
Phase II trial of a paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck.
Sylvie Négrier; Liliane Ollivier; D Di Stefano-Louineau; Bernard Escudier; Jacqueline Savary; Christine Lasset; Philippe Thiesse
[Reliability of the response rate in oncology: analysis of the causes for variation].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jacqueline Savary (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: Xavier Pivot; Christine Chevreau; Didier Cupissol; Alain Lortholary; Nguyen Binh Bui; Jean-Christophe Eymard; Jacques-Olivier Bay; Marie-Christine Baranzelli; Monica Mita; Laurence Barnouin; Jacqueline Savary; Antoine Thyss
Phase II trial of paclitaxel-epirubicin in patients with recurrent soft-tissue sarcoma.
American journal of clinical oncology 2002;25(6):561-4.
2001: Xavier Pivot; L Cals; Didier Cupissol; Emmanuel Guardiola; X Tchiknavorian; P Guerrier; L Merad; J L Wendling; L Barnouin; Jacqueline Savary; Antoine Thyss; M Schneider
Phase II trial of a paclitaxel-carboplatin combination in recurrent squamous cell carcinoma of the head and neck.
Oncology 2001;60(1):66-71.
2000: Sylvie Négrier; Liliane Ollivier; D Di Stefano-Louineau; Bernard Escudier; Jacqueline Savary; Christine Lasset; Philippe Thiesse
[Reliability of the response rate in oncology: analysis of the causes for variation].
Bulletin du cancer 2000;87(12):927-34.
1999: Bernard Escudier; Christine Chevreau; Christine Lasset; Jean-Yves Douillard; Alain Ravaud; M Fabbro; Armelle Caty; Jean-François Rossi; Patrice Viens; Jean-Pierre Bergerat; Jacqueline Savary; Sylvie Négrier
Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2039-43.
1998: Sylvie Negrier; Bernard Escudier; Christine Lasset; Jean-Yves Douillard; Jacqueline Savary; Christine Chevreau; Alain Ravaud; A Mercatello; Jean Peny; Mireille Mousseau; T Philip; T Tursz
Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie.
The New England journal of medicine 1998;338(18):1272-8.
1997: Philippe Thiesse; Liliane Ollivier; D Di Stefano-Louineau; Sylvie Négrier; Jacqueline Savary; K Pignard; Christine Lasset; Bernard Escudier
Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(12):3507-14.